The PE Ratio as of December 2024 (TTM) for Aptorum Group Limited (APM) is -1.39

According to Aptorum Group Limited’s latest financial reports and current stock price. The company's current PE Ratio is -1.39. This represents a change of -5766.25% compared to the average of 0.02 of the last 4 quarters.

Aptorum Group Limited (APM) Historical PE Ratio (quarterly & annually)

How has APM PE Ratio performed in the past?

The mean historical PE Ratio of Aptorum Group Limited over the last ten years is -30.82. The current -1.39 PE Ratio has changed 350.99% with respect to the historical average. Over the past ten years (40 quarters), APM's PE Ratio was at its highest in in the December 2020 quarter at 1.58. The PE Ratio was at its lowest in in the June 2019 quarter at -19.13.

Aptorum Group Limited (APM) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Aptorum Group Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Aptorum Group Limited (APM) Average PE Ratio

How has APM PE Ratio performed in the past?

The current PE Ratio of Aptorum Group Limited (APM) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Aptorum Group Limited (APM) PE Ratio vs. Peers

How is APM’s PE Ratio compared to its peers?

Aptorum Group Limited’s PE Ratio is less than ERYTECH Pharma S.A. (-0.47), less than Surrozen, Inc. (-0.89), greater than Unicycive Therapeutics, Inc. (-2.06), greater than Armata Pharmaceuticals, Inc. (-1.78), less than Applied Molecular Transport Inc. (-0.43), greater than Fresh Tracks Therapeutics, Inc. (-3.09), less than AIM ImmunoTech Inc. (-0.46), less than BioCardia, Inc. (-0.73), greater than Innate Pharma S.A. (-4.56), less than Addex Therapeutics Ltd (1.05), greater than Celyad Oncology SA (-2.42), greater than Dyadic International, Inc. (-8.11), less than Altamira Therapeutics Ltd. (-0.02), less than Dermata Therapeutics, Inc. (-0.18), less than ContraFect Corporation (-0.00), less than eFFECTOR Therapeutics, Inc. (-0.00), less than Aditxt, Inc. (-0.00), less than NeuroBo Pharmaceuticals, Inc. (-0.87), less than Revelation Biosciences, Inc. (-0.05),

Build a custom stock screener for Aptorum Group Limited (APM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aptorum Group Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Aptorum Group Limited (APM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Aptorum Group Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.